Needham & Company LLC reiterated their hold rating on shares of Surmodics (NASDAQ:SRDX – Free Report) in a report published on Wednesday, MarketBeat Ratings reports. A number of other research analysts have also recently issued reports on SRDX. Barrington Research reaffirmed an outperform rating and issued a $71.00 price target on shares of Surmodics in […]
Surmodics (NASDAQ:SRDX – Get Free Report) was downgraded by StockNews.com from a “buy” rating to a “hold” rating in a report issued on Thursday. SRDX has been the topic of a number of other reports. Sidoti restated a “neutral” rating and issued a $43.00 target price on shares of Surmodics in a report on Wednesday. […]
Innate Pharma (NASDAQ:IPHA – Get Free Report) and Vitro Diagnostics (OTCMKTS:VODG – Get Free Report) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, dividends, analyst recommendations, profitability, valuation and risk. Institutional & Insider Ownership 0.2% of Innate Pharma […]
Surmodics (NASDAQ:SRDX) Sees Strong Trading Volume wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.
Surmodics (NASDAQ:SRDX – Get Free Report)‘s stock had its “neutral” rating reiterated by research analysts at Sidoti in a research note issued to investors on Wednesday, Benzinga reports. They presently have a $43.00 price objective on the stock. Sidoti’s price objective points to a potential upside of 2.09% from the company’s current price. Other equities […]